COPENHAGEN, Denmark, Feb. 23, 2023 /PRNewswire/ — Daybreak Well being, a world chief in digital well being, right now introduced a strategic partnership with Novartis, one of many main medicines corporations on the earth, to assist the event of a platform that permits the efficient distant monitoring and administration of sufferers to comprehend a hybrid future for power care and remodel the expertise for all stakeholders.
“We’re thrilled to announce this world partnership with Novartis that goals to unlock a digital first strategy in direction of a extra personalised therapy for sufferers. We see a giant potential in successfully leveraging our shared capabilities, constructing on the Daybreak Well being SaMD platform to assist sufferers affected by a variety of power illnesses”, says Daniel Daugaard, Founder & CEO at Daybreak Well being.
Persistent illnesses are the main explanation for mortality in Europe, representing 86% of all deaths, in response to the Persistent Illness Alliance1. Accordingly, the therapy and administration of those power illnesses are the main drivers of present healthcare prices right now. Nonetheless, power care is experiencing appreciable challenges attributable to important capability constraints and restricted insights into affected person outcomes and sometimes dispersed care of sufferers throughout numerous care groups.
Novartis has chosen Daybreak Well being as their companion and the authorized producer of the envisioned platform in a patient-first strategy that empowers sufferers and their care groups to make higher and sooner therapy choices geared toward enhancing outcomes and managing power illnesses extra proactively and effectively. By combining a affected person cellular software centered on excessive engagement and distinctive UX with modern components like symptom monitoring, novel (digital) biomarkers, medical resolution assist providers, digital clinic capabilities and different related providers as they grow to be out there, the platform might be tailor-made very particularly to the wants and calls for of every separate illness in scope.
Based mostly on a broad portfolio of therapies by Novartis throughout many power illnesses, the partnership might be taking a strategic strategy to prioritize these illnesses that are characterised by excessive ranges of unmet affected person wants, uncertainty about present illness state and development and ensuing cautious approaches to therapy. The intention of any resolution might be to additional empower sufferers by higher monitoring and identification of illness exercise remotely to allow sufferers and their care groups to make well timed and assured therapy choices.
About Daybreak Well being
Daybreak Well being is a world chief in digital well being and a catalyst for spearheading innovation within the healthcare business. The corporate makes a speciality of growth of software program as medical system (SaMD) and digital therapeutics (DTx). The corporate’s mission is to carry analysis, care and expertise along with the intention of serving to 1 million folks dwell longer and higher lives by 2030.
Daybreak Well being Video
Contact, Media Relations
+45 25 13 63 49
The next recordsdata can be found for obtain:
https://mb.cision.com/Most important/21169/3717728/1858122.pdf Press Launch (PDF) https://information.cision.com/dawn-health-a-s/i/press01,c3145678 Press01 https://information.cision.com/dawn-health-a-s/i/press02,c3145679 Press02 https://information.cision.com/dawn-health-a-s/i/press03,c3145680 Press03 https://information.cision.com/dawn-health-a-s/i/press04,c3145681 Press04 https://information.cision.com/dawn-health-a-s/i/press05,c3145682 Press05 https://information.cision.com/dawn-health-a-s/i/press06,c3147150 Press06 https://information.cision.com/dawn-health-a-s/i/press07,c3147151 Press07
SOURCE Daybreak Well being A/S